Skip to main content
Contact Us
Subscribe
E-Edition
67°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Schrodinger Inc
(NQ:
SDGR
)
19.87
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Schrodinger Inc
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
SDGR Stock Earnings: Schrodinger Misses EPS, Misses Revenue for Q1 2024
May 01, 2024
SDGR stock results show that Schrodinger missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
May 01, 2024
Via
Benzinga
Schrödinger Reports First Quarter 2024 Financial Results
May 01, 2024
From
Schrödinger
Via
Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
April 18, 2024
From
Schrödinger
Via
Business Wire
Critical Insights From Schrodinger Analyst Ratings: What You Need To Know
March 01, 2024
Via
Benzinga
Key Takeaways From Schrodinger Analyst Ratings
January 26, 2024
Via
Benzinga
The 10 Stocks In The Clinical-Stage BioTech Drug Stocks Index Are Down 4% YTD
April 15, 2024
The pharmaceutical industry is embracing AI to streamline drug discovery and researching the use of psychedelic compound-based ingredients for the treatment of, as yet, untreatable diseases.
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Schrödinger to Announce First Quarter 2024 Financial Results on May 1
April 10, 2024
From
Schrödinger
Via
Business Wire
5 Healthcare Stocks to Buy for 2024
April 02, 2024
Healthcare stocks have been some of the top performers in 2024, and thanks to the potential of AI, these names will just keep heating up.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Invest Like Bill Gates With These 3 AI Stocks to Buy
March 27, 2024
Bill Gates is undoubtedly interested in AI stocks to buy. Here are three of his foundation’s current holdings.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Shhh! 7 Small-Cap Stocks That Can Double by 2025
March 20, 2024
Small-cap stocks have been hot and these shares discussed here are likely to heat up and double over the next year.
Via
InvestorPlace
Schrödinger Highlights Discovery of SGR-1505, Clinical-Stage MALT1 Inhibitor, at American Chemical Society National Meeting
March 20, 2024
From
Schrödinger
Via
Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
March 19, 2024
From
Schrödinger
Via
Business Wire
Billionaire Bill Gates Has 35% of His Portfolio Invested in These 2 Artificial Intelligence (AI) Stocks: Are They No-Brainer Buys?
March 18, 2024
AI is a key growth driver for both of these stocks owned by the Gates Foundation Trust.
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
10 Health Care Stocks Whale Activity In Today's Session
March 04, 2024
Via
Benzinga
AI-Powered Drug Discovery Stocks Index Up 9% In February; Remains Down 8% YTD
March 04, 2024
Grand View Research says the global
Via
Talk Markets
The Hot List: 3 AI Stocks Worth Buying on Weakness
March 01, 2024
Firms using AI directly can be great picks for long-term investors, such as these three AI stocks to buy on weakness.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
12 Health Care Stocks Moving In Thursday's Pre-Market Session
February 29, 2024
Via
Benzinga
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
February 29, 2024
Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results.
Via
Benzinga
Why Okta Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket
February 29, 2024
Shares of Okta, Inc. (NASDAQ: OKTA) shares rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and
Via
Benzinga
Shoals Technologies Posts Weak Q4 Results, Joins Butterfly Network, Schrödinger And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
February 29, 2024
U.S. stock futures were lower this morning, with the Dow futures trading lower by over 100 points on Thursday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 28, 2024
Via
Benzinga
Schrödinger Reports Strong Fourth Quarter and Full-Year 2023 Financial Results
February 28, 2024
From
Schrödinger
Via
Business Wire
Schrödinger to Participate in Upcoming Investor Conferences
February 20, 2024
From
Schrödinger
Via
Business Wire
Earnings Scheduled For February 28, 2024
February 28, 2024
Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenue of $1.69 billion.
Via
Benzinga
Double Your Money: 3 Growth Stocks to Grab in 2024
February 19, 2024
The Russell 2000 has risen recently as interest rates have climbed, showing that the Street is now more likely to embrace growth stocks.
Via
InvestorPlace
AI-Powered Drug Discovery Stocks Index Up 18% Last Week, Led By BioXcel Therapeutics
February 19, 2024
The AI-powered drug discovery market is projected to grow at a 30% CAGR between now and 2030, with annual sales in excess of $50 billion anticipated. An AI drug discovery revolution is underway.
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
February 16, 2024
From
Schrödinger
Via
Business Wire
Schrödinger to Announce Fourth Quarter and Full-Year 2023 Financial Results on February 28
February 14, 2024
From
Schrödinger
Via
Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
January 19, 2024
From
Schrödinger
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.